Your health is
our priority
Kowa Pharmaceutical Asia Pte.Ltd.

Kowa is committed to the global healthcare community.

Read More

  • Sales ¥459,552m

    Fiscal year ended
    March 31, 2022,
    Kowa Group consolidated
  • Employees 7,922

    As of March 2022,
    Kowa Group consolidated
  • Major subsidiaries 64

    Major Subsidiaries & Affiliates in Japan,
    Asia, North America, Latin America, and Europe

Read More

Rich in knowledge and experience with a vision of a better world

Read More

Our History

Across our entire group, we have more than 100 years of experience in business and we are proud of our Japanese influence and heritage.

Read More

Our Products

The Pharmaceutical Business Unit conducts research, development, and manufacturing of OTC drugs, healthcare products, supplements, Prescription drugs, and medical devices (ophthalmic medical devices, intraocular lenses, etc.) based on flexible ideas and advanced technology.

Read More

Our Treatment areas

Kowa’s wide variety of prescription medicines include oral agents for the treatment of cardiovascular diseases as our specialty segments, topical agents for eye.